期刊文献+

前列地尔序贯疗法联合复方丹参滴丸对老年临床糖尿病肾病的治疗效果分析 被引量:19

Clinical efficacy analysis of combine alprostadil sequential therapy with Danshen driping pillsin treatment of elderly patients with diabetic nephropathy
收藏 分享 导出
摘要 目的探讨前列地尔序贯疗法联合复方丹参滴丸对老年临床糖尿病肾病的治疗效果。方法将老年糖尿病肾病患者80例,随机分为对照组和观察组,每组40例。对照组给予常规治疗+复方丹参滴丸(治疗4周);观察组在对照组的基础上给予前列地尔序贯治疗(前列地尔注射液2周,贝前列素钠片2周)。对2组患者治疗前后总蛋白、血栓素B2、肾血流、24 h尿微量白蛋白(UMA)以及尿6-酮-前列素F1α(6-keto-PGF1α)进行观察。结果治疗后,两组总蛋白和UMA水平显著降低,观察组总蛋白和UMA水平显著低于对照组(P〈0.05);两组肾脏动脉、段动脉及叶间动脉阻力指数(RI)显著降低,观察组RI显著低于对照组(P〈0.05);两组6-keto-PGF1α显著升高,观察组6-keto-PGF1α水平显著高于对照组(P〈0.05);两组血栓素B2显著降低,观察组血栓素B2显著低于对照组(P〈0.05)。结论前列地尔序贯疗法联合复方丹参滴丸可有降低老年临床糖尿病肾病患者尿蛋白水平,改善患者血流动力学。 Objective To investigate clinical efficacy of combine alprostadil sequential therapy with Danshen driping piUs in treatment of elderly patients with diabetic nephropathy. Methods 80 cases of eider patients with diabetic nephropathywere randomly divided into control group and observation group, 40 cases in each group. Patients in control group were given conventional treatment +Danshen driping pills for 4 weeks, and patients in observation group were given alprostadil sequential therapy(alprostadil injection for 2 weeks+beraprost sodium tablets for 2 weeks) based on conventional treatment. The total protein, thromboxane B2,24 h urinary albumin (UMA) and urinary 6-keto-prostaglandin F1α levels and renal blood flow of two groups were observed. Results After treatment, UMA and total protein levels of two groups were significantly reduced, and UMA and total protein levels of observation group were significantly lower than those of control group (P〈0.05); kidney artery, segmental arteries and leaves artery resistance index (RI) of two groups were significantly decreased, and RI of observation group was significantly lower than that of control group (P〈0.05); 6-keto- PGF1α levels of two groups were significantly improved, and 6-keto-PGF1α of observation group was significantly higher than that of control group (P〈0.05); thromboxane B2 levels of two groups were significantly increased,and thromboxane B2 level of observation group was significantly lower than that of control group (P〈0.05). Conclusion Combine alprostadil sequential therapy with Danshen driping pills can effectively reduce the urinary protein level and improve hemodynamic of elderly diabetic nephropathy.
作者 班艳 BAN Yan (Veteran Outpatient Department of Hengshui No.2 People's Hospital, Hengshui, Hebei 053000, China)
出处 《热带医学杂志》 CAS 2015年第2期241-243,共3页 Journal Of Tropical Medicine
关键词 糖尿病肾病 前列地尔 贝前列素钠片 diabetic nephropathy alprostadil beraprost sodium tablets
  • 相关文献

参考文献10

二级参考文献77

同被引文献109

  • 1白晓宁,侯敏全,王惠芳.厄贝沙坦联合复方丹参滴丸治疗对老年早期2型糖尿病肾病患者尿微量清蛋白的影响[J].中国全科医学,2008(20):1839-1841. 被引量:43
  • 2陈明芝.中医益气补肾化瘀法治疗早期糖尿病肾病50例分析[J].当代医药论丛:下半月,2013,0(7):132-132. 被引量:5
  • 3鲍领芝,杨光,王海彬.复方丹参滴丸治疗糖尿病视网膜病变临床观察[J].河北中医,2006,28(4):304-305. 被引量:8
  • 4Collins AT, Kasiske B, Herzog C, et al. United States renal data system 2006 annual Data report abstract[ J]. Am J Kidney Dis ,2007,49 (ISuP- PII) :A6 -7. 被引量:1
  • 5聂莉.序贯疗法l临床应用研究[J].中国药物经济学,2014,(2):280-281. 被引量:1
  • 6Viedt C, Dechend R, Fei J, et al. MCP-1 Induces Inflammatory Activation of Human Tubular E pithehal Ceils: Involvement of the Transcription Factors, Nuclear Factor-KB and Activating Protein-1 [ J ]. J Am Soc Nephro1,2012,13 (6) : 1'534 - 1547. 被引量:1
  • 7Bourlon PM Faure-Dussert A, Billaudel B. The de novo synthesis of nu- merous proteins is decreased,during vitamin D3 deficiency and is gradu- ally restored by 1,25-dihydroxyvitamin D3 repletion in the islets of langerhans of rats [ J ]. J Endocrino1,2013,162 ( 1 ) : 101 - 109. 被引量:1
  • 8WANG SS, CHANG BC, SHAN CY, et al. Clinical effect of sequential therapy with alprostadil and beraprostin elderly patients with clinical diabeticne phropathy[J].Chin J Geriatr, 2014,33(2) :154-158. 被引量:1
  • 9Leiter LA,Carr MC,Stewart M,et al.Efficacy and safety of the onceweekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment:a randomized phaseⅢstudy. Diabetes Care . 2014 被引量:1
  • 10M.Ligueros‐Saylan,J. E.Foley,A.Schweizer,A.Couturier,W.Kothny.??An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials(J)Diabetes, Obesity and Metabolism . 2010 (6) 被引量:1

引证文献19

二级引证文献38

投稿分析
职称考试

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈